Not exact matches
The racially diverse study sample consisted of two groups: 89 patients diagnosed with low risk prostate cancer (clinical stage T1 - T2a, biopsy Gleason score 6 or less, and prostate specific
antigen less than 10 ng / ml), who initially underwent
AS, and 420 patients
without cancer who had a negative prostate needle biopsy.
The scientists took the genes for the most effective liver cancer
antigen receptors on those T cells, put those receptors on human T cells and the resulting engineered human T cells eradicated the cancer
as well,
without hurting normal liver cells, they report in the journal Hepatology.
Designed to target multiple conserved
antigens without antigen competition,
as well
as patient - specific neoantigens, with immunostimulatory molecules